Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.)

Scopus

Scopus profile and journal metrics

This journal is indexed in Scopus. Use these metrics for a quick publishing snapshot, then open the Scopus page for the authoritative profile.

Scopus
Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.) Indexed in Scopus since 2022
CiteScore 1.0
Indexed since 2022
First decision 7 Days
Submission to acceptance 45 Days
Acceptance to publication 14 Days
Acceptance rate 8%

SCImago

SCImago Journal Rank preview

Use SCImago when you want a quick visual view of the journal ranking profile and external discoverability signals.

Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.) SCImago Journal & Country Rank

DOAJ

Directory of Open Access Journals listing

The DOAJ record is useful for readers, librarians, and authors who want a direct open-access directory entry for the journal.

DOAJ
Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.) Open directory record
Original full research article

Beneficial roles of sustained release formulations of diacerein microspheres in com-parison to free diacerein incomplete Freund's adjuvant (C.F.A.) induced arthritis model in rat

Published
2022-12-10
Pages
197 - 214
Full text

Keywords

  • Microsphere
  • Diacerein
  • Rheumatoid arthritis
  • Sprague Dawley rats

Abstract

Diacerein is an anti-inflammatory drug used to treat osteoarthritis. Available dosage forms of diacerein cannot reduce its main adverse effects like soft stool and diarrhea. The main aim of this work is to evaluate the antiarthritic effects of diacerein microsphere in the complete Freund's adjuvant (C.F.A.)-induced arthritis model in rats and on intestinal meal transit and peristaltic index. Diacerein microspheres were administered to experimental rats via oral routes. Five experimental groups of Sprague Dawley rats were considered: Group I (Negative control group), Group II (Positive control group), Group III or test group (Diacerein microsphere treated group), Group IV or Standard I group [Diacerein API (active pharmaceu-tical ingredient) treated group], Group V or Standard II group (Glucosamine treated group). Glucosamine was considered a standard drug because it has a similar mechanism of action to diacerein (IL-1β inhibition), and various literature reviews showed that it has antiarthritic and cartilage protective effects. Various antiarthritic effects like paw volume, joint stiffness, ar-thritic index, gait test, body weight measurement, and X-ray of tibiotarsal joints were evaluat-ed in test group rats and compared to standard I standard II group. The Diacerein micro-sphere-treated group showed similar results compared to the standard I and II groups. A char-coal meal test was performed on fresh, experimental animals, and results showed that the di-acerein microsphere causes the sustained release of diacerein so that diacerein-mediated diar-rhea is reduced.

Article history

Received
2021-09-11
Accepted
2022-12-10
بحث أصيل كامل

Beneficial roles of sustained release formulations of diacerein microspheres in com-parison to free diacerein incomplete Freund's adjuvant (C.F.A.) induced arthritis model in rat

Published
2022-12-10
الصفحات
197 - 214
البحث كاملا

الكلمات الإفتتاحية

  • Microsphere
  • Diacerein
  • Rheumatoid arthritis
  • Sprague Dawley rats

الملخص

Diacerein is an anti-inflammatory drug used to treat osteoarthritis. Available dosage forms of diacerein cannot reduce its main adverse effects like soft stool and diarrhea. The main aim of this work is to evaluate the antiarthritic effects of diacerein microsphere in the complete Freund's adjuvant (C.F.A.)-induced arthritis model in rats and on intestinal meal transit and peristaltic index. Diacerein microspheres were administered to experimental rats via oral routes. Five experimental groups of Sprague Dawley rats were considered: Group I (Negative control group), Group II (Positive control group), Group III or test group (Diacerein microsphere treated group), Group IV or Standard I group [Diacerein API (active pharmaceu-tical ingredient) treated group], Group V or Standard II group (Glucosamine treated group). Glucosamine was considered a standard drug because it has a similar mechanism of action to diacerein (IL-1β inhibition), and various literature reviews showed that it has antiarthritic and cartilage protective effects. Various antiarthritic effects like paw volume, joint stiffness, ar-thritic index, gait test, body weight measurement, and X-ray of tibiotarsal joints were evaluat-ed in test group rats and compared to standard I standard II group. The Diacerein micro-sphere-treated group showed similar results compared to the standard I and II groups. A char-coal meal test was performed on fresh, experimental animals, and results showed that the di-acerein microsphere causes the sustained release of diacerein so that diacerein-mediated diar-rhea is reduced.

Article history

تاريخ التسليم
2021-09-11
تاريخ القبول
2022-12-10